Home › Funds › Temasek Holdings (Private) Ltd › BNTX
Temasek Holdings (Private) Ltd position in BNTX
BIONTECH SE · Health Care
Temasek Holdings (Private) Ltd reported holding 1,506,027 shares of BNTX (BIONTECH SE) in its Q2 2026 13F filing — a position valued at US$140.1M, representing 0.44% of its reported portfolio and ranking #45 among its reported holdings. Temasek Holdings (Private) Ltd has disclosed BNTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Temasek Holdings (Private) Ltd's BNTX position evolved
Temasek Holdings (Private) Ltd first disclosed a stake in BNTX in Q3 2023 at 4,518,080 shares (US$490.8M). Across 12 filings, Temasek Holdings (Private) Ltd increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 1,506,027 shares valued at US$140.1M. Notable position changes include a 47% trim in Q2 2024 (shares rose 48% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.52M | $490.84M | New |
| Q4 2023 | 4.52M | $476.84M | Hold |
| Q1 2024 | 3.43M | $316.44M | Reduce |
| Q2 2024 | 1.81M | $145.23M | Reduce |
| Q3 2024 | 1.81M | $214.64M | Hold |
| Q4 2024 | 1.81M | $205.93M | Hold |
| Q1 2025 | 1.81M | $164.57M | Hold |
| Q2 2025 | 1.51M | $160.35M | Reduce |
| Q3 2025 | 1.51M | $148.52M | Hold |
| Q4 2025 | 1.51M | $143.37M | Hold |
| Q1 2026 | 1.51M | $133.86M | Hold |
| Q2 2026 | 1.51M | $140.14M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BNTX and 13F data
BNTX (BIONTECH SE) is a Health Care company. 34 other funds we track also report a position in BNTX — the largest reported positions include FLOSSBACH VON STORCH SE (US$207.1M), Logos Global Management LP (US$94.4M), GSK plc (US$82.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BNTX
- FLOSSBACH VON STORCH SE 2.23M sh · $207.14M · Q2 2026
- Logos Global Management LP 1.01M sh · $94.45M · Q2 2026
- GSK plc 889.82K sh · $82.80M · Q2 2026
- Davern Capital Partners, LP 754.55K sh · $70.21M · Q2 2026
- Long Focus Capital Management, LLC 624.00K sh · $58.06M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 470.00K sh · $43.73M · Q2 2026
More on Temasek Holdings (Private) Ltd
FAQ
How long has Temasek Holdings (Private) Ltd held BNTX?
Temasek Holdings (Private) Ltd has disclosed BNTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Temasek Holdings (Private) Ltd's current position in BNTX?
As of Q2 2026, Temasek Holdings (Private) Ltd holds 1.51M shares of BNTX (BIONTECH SE), valued at $140.14M, representing 0.44% of its reported portfolio and ranking #45.
Has Temasek Holdings (Private) Ltd been buying or selling BNTX?
In the latest 13F filing (Q2 2026), Temasek Holdings (Private) Ltd held unchanged its position in BNTX.
Which other funds hold BNTX?
Other major institutional holders of BNTX include FLOSSBACH VON STORCH SE, Logos Global Management LP, GSK plc, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.